Snowball logo
logo
RVLP

RVL Pharmaceuticals PLC

-- $0,00 $  (0%)
Оценка
EPS
-0,71
Рост
Выручка, YoY
-2,25%
Чистый доход, YoY
-97,33%
FCF, YoY
-756,71%
Прогноз
EPS (FWD)
-0,3
Другое
Размер лота
1 шт.
О компании
Тикер
RVLP
ISIN
IE00BF2HDL56
Страна
США
Сектор (GICS)
Здравоохранение
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

Часто задаваемые вопросы

В каком секторе работает RVL Pharmaceuticals PLC (RVLP)?

RVL Pharmaceuticals PLC относится к сектору Здравоохранение.

Выплачивает ли RVL Pharmaceuticals PLC (RVLP) дивиденды?

Нет, RVL Pharmaceuticals PLC не выплачивает дивиденды.